Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225522797> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4225522797 abstract "Vascular Behçet's disease (VBD) is a systemic vasculitis involving both arterial and venous vessels of all sizes and occurring in up to 40% of patients with BD. VBD is the main cause of mortality in BD. Although commonly seen around the Mediterranean region, comparative studies in VBD are lacking. We aimed to compare the course and therapeutic approaches of VBD in two large cohorts from Turkey and France.We included 291 VBD patients (female/male:63/228, mean age: 41.2±11.3 years) who were followed up in the Department of Internal Medicine and Clinical Immunology at Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France (n=131) and Rheumatology Division of Marmara University School of Medicine, Istanbul, Turkey (n=160). All clinical and demographical data were acquired from patient charts retrospectively.Smoking, family history for BD, HLA-B*51 presence and pathergy positivity were significantly higher in Turkish patients (TR), while neurologic involvement was more prominent in the French (FR) group. After a median follow-up of 77 months, 562 vascular events occurred including 440 venous events, 115 arterial events and 7 cardiac thrombi. In 79 (29%) patients, first vascular event developed before BD diagnosis and for 77 (28%) of them, vascular involvement was the presenting sign of the disease. First relapse developed in 130 (44.7%) patients after median 24.5 (1-276) months of follow-up (TR: 46.3% (n=74), FR: 42.7% (n=56), p=0.56). Survival graph revealed that FR cohort has 1.64 times increased recurrent event risk compared to TR cohort (HR=1.64 (1.1-2.44), p=.014) and although did not reach to statistical significance, IS treatment after the first vascular event decreased further vascular events (HR= 0.66 (0.43-1.01, p=.057).Almost half of patients relapsed of VBD within 2 years after the first vascular event. Immunosuppressants decrease VBD relapses." @default.
- W4225522797 created "2022-05-05" @default.
- W4225522797 creator A5014787454 @default.
- W4225522797 creator A5019220311 @default.
- W4225522797 creator A5029797000 @default.
- W4225522797 creator A5037078532 @default.
- W4225522797 creator A5041173817 @default.
- W4225522797 creator A5059327713 @default.
- W4225522797 creator A5059396954 @default.
- W4225522797 creator A5076379466 @default.
- W4225522797 creator A5085912537 @default.
- W4225522797 date "2021-07-20" @default.
- W4225522797 modified "2023-10-18" @default.
- W4225522797 title "Vascular Behçet's disease: a comparative study from Turkey and France" @default.
- W4225522797 doi "https://doi.org/10.55563/clinexprheumatol/iovig5" @default.
- W4225522797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35200121" @default.
- W4225522797 hasPublicationYear "2021" @default.
- W4225522797 type Work @default.
- W4225522797 citedByCount "1" @default.
- W4225522797 countsByYear W42255227972022 @default.
- W4225522797 crossrefType "journal-article" @default.
- W4225522797 hasAuthorship W4225522797A5014787454 @default.
- W4225522797 hasAuthorship W4225522797A5019220311 @default.
- W4225522797 hasAuthorship W4225522797A5029797000 @default.
- W4225522797 hasAuthorship W4225522797A5037078532 @default.
- W4225522797 hasAuthorship W4225522797A5041173817 @default.
- W4225522797 hasAuthorship W4225522797A5059327713 @default.
- W4225522797 hasAuthorship W4225522797A5059396954 @default.
- W4225522797 hasAuthorship W4225522797A5076379466 @default.
- W4225522797 hasAuthorship W4225522797A5085912537 @default.
- W4225522797 hasBestOaLocation W42255227971 @default.
- W4225522797 hasConcept C126322002 @default.
- W4225522797 hasConcept C141071460 @default.
- W4225522797 hasConcept C198451711 @default.
- W4225522797 hasConcept C2776015282 @default.
- W4225522797 hasConcept C2777374719 @default.
- W4225522797 hasConcept C2779134260 @default.
- W4225522797 hasConcept C2781428731 @default.
- W4225522797 hasConcept C71924100 @default.
- W4225522797 hasConcept C72563966 @default.
- W4225522797 hasConceptScore W4225522797C126322002 @default.
- W4225522797 hasConceptScore W4225522797C141071460 @default.
- W4225522797 hasConceptScore W4225522797C198451711 @default.
- W4225522797 hasConceptScore W4225522797C2776015282 @default.
- W4225522797 hasConceptScore W4225522797C2777374719 @default.
- W4225522797 hasConceptScore W4225522797C2779134260 @default.
- W4225522797 hasConceptScore W4225522797C2781428731 @default.
- W4225522797 hasConceptScore W4225522797C71924100 @default.
- W4225522797 hasConceptScore W4225522797C72563966 @default.
- W4225522797 hasLocation W42255227971 @default.
- W4225522797 hasLocation W42255227972 @default.
- W4225522797 hasLocation W42255227973 @default.
- W4225522797 hasLocation W42255227974 @default.
- W4225522797 hasOpenAccess W4225522797 @default.
- W4225522797 hasPrimaryLocation W42255227971 @default.
- W4225522797 hasRelatedWork W2009963017 @default.
- W4225522797 hasRelatedWork W2034379598 @default.
- W4225522797 hasRelatedWork W2080282662 @default.
- W4225522797 hasRelatedWork W2082940938 @default.
- W4225522797 hasRelatedWork W2165377620 @default.
- W4225522797 hasRelatedWork W2415157810 @default.
- W4225522797 hasRelatedWork W2418803871 @default.
- W4225522797 hasRelatedWork W2773342590 @default.
- W4225522797 hasRelatedWork W3161636978 @default.
- W4225522797 hasRelatedWork W4210391435 @default.
- W4225522797 isParatext "false" @default.
- W4225522797 isRetracted "false" @default.
- W4225522797 workType "article" @default.